Literature DB >> 7947039

Progression of chronic renal failure in a historical group of patients with nephropathic cystinosis. European Collaborative Study on Cystinosis.

F Manz1, N Gretz.   

Abstract

In a historical group of 205 patients with infantile or adolescent cystinosis treated without cysteamine, the rate of deterioration of renal function was analysed retrospectively. Patient survival curves and renal survival data are presented. Longitudinal data of serum creatinine values (n = 3280) in 157 patients were plotted for each patient, smoothed by the method of the running medians and grouped into 12 serum creatinine classes. In every patient the age at the last smoothed serum creatinine value observed in each serum creatinine class was determined. These virtual age values were then summarized per serum creatinine class, expressed as median and centiles and plotted, thus describing the "natural" course of the disease. In 9 pairs of affected siblings the rate of progression showed a median difference of about 12 months. Our data describe the "natural" course of nephropathic cystinosis and can be used as a prognostic aid for recently detected patients. The data can also be applied for the assessment of the influence of new therapeutic strategies on the rate of progression of renal failure in cystinotic patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947039     DOI: 10.1007/bf00856532

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  24 in total

Review 1.  Physiologic adaptations of the tubuloglomerular feedback system.

Authors:  R C Blantz; S C Thomson; O W Peterson; F B Gabbai
Journal:  Kidney Int       Date:  1990-10       Impact factor: 10.612

2.  Combined report on regular dialysis and transplantation of children in Europe, 1989.

Authors:  J H Ehrich; G Rizzoni; F P Brunner; H Brynger; W Geerlings; W Fassbinder; A E Raine; N H Selwood; G Tufveson
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

Review 3.  Cystinosis.

Authors:  J D Schulman
Journal:  Prog Clin Biol Res       Date:  1989

4.  [Evaluation of the dietary treatment of cystinosis].

Authors:  H Schmidt; P Lutz; H Bickel
Journal:  Monatsschr Kinderheilkd       Date:  1973-05

Review 5.  How to assess the rate of progression of chronic renal failure in children?

Authors:  N M Gretz
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

6.  Long-term treatment of infantile nephropathic cystinosis with cysteamine.

Authors:  V A da Silva; R P Zurbrügg; P Lavanchy; A Blumberg; H Suter; S R Wyss; C M Lüthy; O H Oetliker
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

7.  [Kidney changes in infantile and adolescent (nephropathic) cystinosis].

Authors:  R Waldherr; F Manz; H Hagge
Journal:  Verh Dtsch Ges Pathol       Date:  1982

8.  Ascorbic acid treatment in nephropathic cystinosis in identical twins.

Authors:  S E Oberfield; L S Levine; D Wellner; M Novogroder; P Laino; M I New
Journal:  Dev Pharmacol Ther       Date:  1981

9.  Ineffectiveness of ascorbic acid therapy in nephropathic cystinosis.

Authors:  J A Schneider; J J Schlesselman; S A Mendoza; S Orloff; J G Thoene; W A Kroll; A D Godfrey; J D Schulman
Journal:  N Engl J Med       Date:  1979-04-05       Impact factor: 91.245

10.  Nephropathic cystinosis: effect of long-term cysteamine therapy.

Authors:  W Proesmans; E Baten; J Hoogmartens; P Bruyneel
Journal:  Clin Nephrol       Date:  1987-06       Impact factor: 0.975

View more
  16 in total

Review 1.  How to assess the rate of progression of chronic renal failure in children?

Authors:  N M Gretz
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

2.  The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire.

Authors:  W G van't Hoff; N Gretz
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

3.  Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.

Authors:  Galina Nesterova; Caitlyn Williams; Isa Bernardini; William A Gahl
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

4.  The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis.

Authors:  Rezan Topaloglu; Bora Gulhan; Mihriban İnözü; Nur Canpolat; Alev Yilmaz; Aytül Noyan; İsmail Dursun; İbrahim Gökçe; Metin Kaya Gürgöze; Nurver Akinci; Esra Baskin; Erkin Serdaroğlu; Beltinge Demircioğlu Kiliç; Selçuk Yüksel; Duygu Övünç Hacihamdioğlu; Emine Korkmaz; Mutlu Hayran; Fatih Ozaltin
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

5.  Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.

Authors:  Marcella Greco; Milena Brugnara; Marco Zaffanello; Anna Taranta; Anna Pastore; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-08-29       Impact factor: 3.714

6.  Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis.

Authors:  Poonam Sansanwal; Benedict Yen; William A Gahl; Yewei Ma; Lihua Ying; Lee-Jun C Wong; Minnie M Sarwal
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

Review 7.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 8.  Proteinuria and events beyond the slit.

Authors:  Rikke Nielsen; Erik Ilsø Christensen
Journal:  Pediatr Nephrol       Date:  2010-01-05       Impact factor: 3.714

Review 9.  Recent advances in the treatment of cystinosis.

Authors:  J A Schneider; K F Clark; A A Greene; J S Reisch; T C Markello; W A Gahl; J G Thoene; P K Noonan; K A Berry
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 10.  Cystinosis: the evolution of a treatable disease.

Authors:  Galina Nesterova; William A Gahl
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.